Why is high fluid intake necessary when taking Jardiance (empagliflozin) to prevent dehydration and related adverse effects?

Why Maximum Fluid Intake Is Necessary with Jardiance

You need to maintain adequate fluid intake with Jardiance (empagliflozin) because the drug causes therapeutic glycosuria and osmotic diuresis, leading to increased urinary fluid losses that can result in volume depletion, hypotension, and acute kidney injury if not compensated.

Mechanism of Fluid Loss

• Jardiance inhibits SGLT2 sodium-glucose cotransporters in the proximal renal tubule, causing excretion of approximately 50-100 grams of glucose per 24 hours in the urine 1, 2.
• This glucose excretion creates an osmotic diuretic effect, pulling additional water into the urine and increasing total fluid losses beyond normal baseline 2, 3.
• The osmotic diuresis results in clinically measurable reductions in blood pressure (systolic approximately 4 mmHg, diastolic approximately 2 mmHg) due to volume contraction 2.

Risk of Volume Depletion and Hypotension

• The FDA drug label explicitly warns that hypotension may occur with Jardiance and advises patients to maintain adequate fluid intake to reduce this risk 4.
• Dehydration increases the risk for hypotension, and patients must be counseled to have adequate fluid intake throughout treatment 4.
• Volume depletion risk is particularly elevated in elderly patients, those with baseline eGFR <60 mL/min/1.73 m², patients on concurrent diuretics, and those with low baseline systolic blood pressure 5, 6.

Risk of Acute Kidney Injury

• The FDA label instructs patients to seek medical advice immediately if they have reduced oral intake (such as due to acute illness or fasting) or increased fluid losses (such as due to vomiting, diarrhea, or excessive heat exposure), as it may be appropriate to temporarily discontinue Jardiance in those settings 4.
• Acute kidney injury has been reported during use of Jardiance, particularly when fluid intake is inadequate to compensate for the drug's diuretic effect 4.
• The 2023 consensus recommendations for sick day medication guidance specify that patients should temporarily stop SGLT2 inhibitors like Jardiance when they cannot keep up with fluid intake or experience vomiting/diarrhea resulting in significant fluid losses 7.

High-Risk Clinical Scenarios Requiring Enhanced Fluid Vigilance

• Acute illness with reduced oral intake: Patients must stop Jardiance during fever, vomiting, diarrhea, or any condition limiting fluid consumption 7, 4.
• Perioperative periods: Jardiance should be discontinued at least 3 days before major surgery or procedures requiring prolonged fasting to prevent volume depletion and ketoacidosis 6, 4.
• Concurrent diuretic therapy: Patients on loop diuretics, thiazides, or potassium-sparing diuretics face compounded volume depletion risk and may require diuretic dose reduction when starting Jardiance 7, 5.
• Hot weather or excessive heat exposure: Increased insensible fluid losses combined with Jardiance-induced diuresis create additive dehydration risk 4.

Monitoring for Volume Depletion

• Healthcare providers should assess volume status before initiating Jardiance and monitor for signs and symptoms of volume depletion throughout therapy, including dizziness, lightheadedness, orthostatic hypotension, and syncope 5.
• Baseline blood pressure documentation is recommended, especially if systolic BP <100 mmHg, before starting Jardiance 5.
• More frequent monitoring of renal function is needed in patients with baseline eGFR 30-60 mL/min/1.73 m² or those at risk for acute kidney injury 5.

Patient Education Essentials

• The FDA label mandates that patients be informed about the importance of adequate fluid intake and the risk of dehydration increasing hypotension 4.
• Patients should be counseled to temporarily discontinue Jardiance and seek medical attention if they develop reduced oral intake, vomiting, diarrhea, or excessive fluid losses 4.
• Warning signs requiring immediate medical evaluation include severe dizziness, fainting, rapid heart rate, or decreased urine output 7.

Common Pitfall to Avoid

• Do not assume that "normal" fluid intake is sufficient—patients must actively increase fluid consumption above their baseline to compensate for the 50-100 grams of glucose and associated water lost daily through therapeutic glycosuria 1, 2.
• The diuretic effect is continuous as long as the patient takes Jardiance, so fluid vigilance must be maintained throughout the entire treatment duration, not just during initiation 2, 3.